4-CL-PVP Crystals
4-CL-PVP Crystals Price range: € 23,90 through € 79,50
Back to products
Pagoclone Pellets 10mg cyclopyrrolone research material from Raw Lab Chems
Pagoclone Pellets - 10mg Price range: € 12,50 through € 237,50

O-DSMT Pellets – 50mg

Price range: € 24,75 through € 98,75

O-DSMT Pellets 50mg are described as compressed research preparations associated with O-desmethyltramadol, also known as desmetramadol.

O-desmethyltramadol is an active metabolite of tramadol and a compound with μ-opioid receptor activity.

The supplied source identifies solid pressed pellets with a labeled analyte quantity of 50mg per finished unit.

This quantity has not been independently verified through finished-unit testing.

The described scientific context includes chemical identity assessment, chromatographic characterization, metabolite analysis, and controlled non-clinical investigation of opioid-related compounds.

The source reports CAS number 80456-81-1, molecular formula C15H23NO2, and molecular weight approximately 249.35 g/mol for the neutral compound.

It also claims ingredient purity of approximately 98–99%, third-party testing, batch tracking, and ISO-aligned manufacturing.

No actual batch-specific analytical reports or manufacturing certifications were supplied.

Chemical form, stereochemical composition, ingredient purity, finished-unit content, content uniformity, excipients, and storage stability remain unverified.

The pellets are not established as certified reference materials or validated quantitative calibration standards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12716 Category:
Description

O-DSMT Pellets 50mg – Desmetramadol Research Material

O-DSMT Pellets 50mg – Product Overview

O-DSMT Pellets 50mg is the supplied catalog designation for a compressed-pellet research preparation associated with O-desmethyltramadol.

O-desmethyltramadol, also called desmetramadol, is an active metabolite of tramadol.

The compound is associated with μ-opioid receptor activity and is relevant to analytical investigation of tramadol-related metabolites.

The supplied source describes solid pressed pellets with a labeled analyte quantity per finished unit.

This labeled amount is a source-provided specification rather than an independently confirmed analytical measurement.

No finished-unit assay, content-uniformity study, or batch-specific quantitative report accompanied the information.

The source positions the preparation for controlled analytical and non-clinical laboratory research.

The stated scientific contexts include chemical identification, chromatographic characterization, metabolite analysis, and investigation of opioid-related molecular systems.

These research contexts should not be confused with verified analytical performance of the actual finished pellets.

The supplied information also refers to independent testing, batch records, and Certificate of Analysis documentation.

However, no supporting laboratory certificates or batch-specific analytical results were provided.

The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies the named compound as O-desmethyltramadol, also known as desmetramadol.

It is an O-demethylated metabolite of tramadol and belongs to a group of opioid-active compounds structurally related to phenylpropylamine-derived analgesic agents.

The supplied chemical information includes:

  • Common designation: O-DSMT
  • Chemical name: O-Desmethyltramadol
  • Alternative name: Desmetramadol
  • Reported CAS Registry Number: 80456-81-1
  • Reported molecular formula: C15H23NO2
  • Calculated molecular weight: Approximately 249.35 g/mol
  • Chemical classification: Tramadol metabolite and opioid-active compound
  • Reported presentation: Solid pressed pellets
  • Labeled analyte amount: 50mg per finished pellet
  • Intended designation: Research Use Only

The reported molecular formula and calculated molecular weight are internally consistent for neutral O-desmethyltramadol.

However, the source does not establish the actual chemical form of the finished product.

A salt form would have a different molecular composition and molecular weight from the neutral compound.

The source supplies a stereochemically specified systematic name while also referring to racemic and enantiomer-specific variants.

Those descriptions should not be treated as equivalent.

The actual stereochemical composition requires confirmation from appropriate structural and analytical records.

The molecular identity of the named ingredient does not establish the composition of the finished pellet.

Additional formulation components may be present, but no excipient specification was supplied.

Researchers may consult PubChem for public chemical-reference information, ensuring that any selected record corresponds to the actual molecular structure, stereochemistry, and chemical form.

Chemical & Physical Characteristics

The supplied source describes the product as white to off-white compressed pellets of consistent physical appearance.

No actual product-specific physical inspection report, image verification, or batch appearance record was supplied.

The reported appearance therefore remains a supplier-provided description.

A compressed pellet is a finished preparation that may contain the named analyte together with additional formulation components.

The source does not identify pellet dimensions, total unit mass, compression characteristics, excipient composition, or manufacturing method.

O-desmethyltramadol is structurally related to tramadol through O-demethylation.

This structural relationship is relevant to chemical identity records and metabolite analysis.

The source describes general solubility in common organic solvents.

However, no product-specific solubility measurements, solvent compatibility records, or finished-pellet extraction studies were supplied.

No validated dissolution, recovery, or stability data were provided for the complete preparation.

The source also does not establish whether the analyte is distributed uniformly within each finished pellet.

Consequently, no definitive claim is made about the physical behavior or analytical recovery of the finished preparation.

Purity & Analytical Verification

The supplied source claims typical ingredient purity of approximately 98–99%.

It also refers to independent analytical verification and controlled impurity levels.

No actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory report was supplied.

The claimed purity and impurity limits therefore remain unverified.

For O-DSMT Pellets 50mg, ingredient purity and finished-unit composition are separate analytical characteristics.

An ingredient-purity result does not independently establish the actual quantity of analyte in a finished pellet.

Likewise, the labeled analyte amount does not establish content uniformity across a batch.

The source refers to HPLC, LC-MS, and NMR spectroscopy as analytical techniques relevant to characterization.

However, no product-specific results were supplied demonstrating identification, purity assessment, or quantitative recovery of O-desmethyltramadol from the finished preparation.

The source does not establish a validated quantitative method, assigned reference value, or measurement uncertainty.

The preparation should therefore not be described as a certified quantitative reference standard.

Any definitive claims about purity, identity, composition, or uniformity require supporting analytical records for the actual batch.

Quality Control & Batch Integrity

The source refers to third-party testing, batch-specific tracking, complete documentation, ICH-aligned practices, and ISO-aligned production conditions.

These are supplier-provided quality-assurance claims.

No actual third-party report, batch record, manufacturing audit, or ISO certification was supplied.

The claims therefore remain unverified.

For a finished-pellet preparation, batch documentation should distinguish the identity and analytical characteristics of the named ingredient from the characteristics of the complete unit.

The source does not establish whether the labeled analyte quantity was independently measured after formulation.

It also does not provide evidence of finished-unit content uniformity or batch-to-batch consistency.

For O-DSMT Pellets 50mg, the distinction between nominal analyte content and verified finished-unit composition is particularly important.

The Research Use Only designation describes intended positioning but does not independently demonstrate quality, traceability, or validated analytical performance.

Claims concerning independent verification, ISO alignment, ICH alignment, and batch consistency should be supported by actual records.

Safety, Handling & Laboratory Precautions

O-desmethyltramadol is an opioid-active compound associated with μ-opioid receptor activity.

Opioid exposure can cause serious central nervous system depression and potentially fatal respiratory depression.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The compressed-pellet presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual chemical form, ingredient purity, excipient composition, and finished-unit content have not been independently confirmed, laboratory records should clearly distinguish supplier-provided specifications from verified findings.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes light-resistant, moisture-resistant packaging, batch-aware handling, tracking, and professional shipment arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was supplied.

The source recommends storage in a cool, dry, low-humidity environment protected from light.

It also suggests refrigeration at approximately 2–8°C.

No validated stability study was provided for the finished-pellet preparation.

The suggested temperature range therefore cannot be presented as a verified requirement or as evidence of a particular shelf life.

For O-DSMT Pellets 50mg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places O-desmethyltramadol within analytical research involving tramadol metabolism, chemical identification, and characterization of opioid-related compounds.

The relationship between tramadol and its O-demethylated metabolite is relevant to chemical identity records and analytical interpretation.

The source describes interest in chromatographic characterization, forensic analytical studies, and investigation of opioid receptor-associated molecular systems.

However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual pellets.

The Raw Lab Chems catalog identifies O-DSMT Pellets as the product listing discussed here.

For broader opioid-related catalog context, the supplied source also identifies 2-Methyl-AP-237 HCl Powder and 2-Methyl-AP-237 HCl Pellets.

These related listings concern a different synthetic opioid compound and should not be treated as chemically identical to O-desmethyltramadol.

The supplied information does not establish equivalent chemical purity, finished-unit content, excipient composition, toxicological properties, or analytical performance across these products.

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes professional packaging, international shipping, tracking, and secure handling arrangements.

No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.

O-desmethyltramadol may be subject to controlled-substance, pharmaceutical, analogue, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

O-desmethyltramadol is an opioid-active compound whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (pellets)

5

,

10

,

25

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “O-DSMT Pellets – 50mg”
Shipping & Delivery